Related references
Note: Only part of the references are listed.Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
Guang Chen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression
Eva G. Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F. Ionescu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
Orly Lipsitz et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2021)
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
Hartej Gill et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial
Jennifer B. Dwyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Changes in Drug Use Patterns during the COVID-19 Pandemic in Italy: Monitoring a Vulnerable Group by Hair Analysis
Alessio Gili et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression
Nichole Roxas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
Samuel T. Wilkinson et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2021)
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3
Rachel Ochs-Ross et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
Fernanda S. Correia-Melo et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Teodora Doherty et al.
CNS DRUGS (2020)
Prenatal Exposure to Ketamine Leads to Anxiety-Like Behaviors and Dysfunction in Bed Nucleus of Stria Terminalis
Jing Sun et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
Urothelial toxicity of esketamine in the treatment of depression
Hannelore Findeis et al.
PSYCHOPHARMACOLOGY (2020)
The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
Veronika Andrashko et al.
FRONTIERS IN PSYCHIATRY (2020)
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
Ewa Wajs et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Prevalence of drugs of abuse found in testing of illicit drug seizures and urinalysis of selected population in Hong Kong
Wing-Chi Cheng et al.
FORENSIC SCIENCE INTERNATIONAL (2019)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
A Word to the Wise About Intranasal Esketamine
Alan F. Schatzberg
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine
Gerard Sanacora
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
Marie Spies et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor
R. B. Katz et al.
GENERAL HOSPITAL PSYCHIATRY (2018)
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Mark J. Niciu et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia
Wan-Ju Cheng et al.
SCHIZOPHRENIA RESEARCH (2018)
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital
Samuel T. Wilkinson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
Cristina Cusin et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use
C. Sophia Albott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
Samuel T. Wilkinson et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
Changes to the bladder epithelial barrier are associated with ketamine-induced cystitis
Qixin Duan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Ketamine administered pregnant rats impair learning and memory in offspring via the CREB pathway
Xinran Li et al.
ONCOTARGET (2017)
A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Y. -D. Hu et al.
PSYCHOLOGICAL MEDICINE (2016)
Ketamine-Induced Apoptosis in Normal Human Urothelial Cells A Direct, N-Methyl-D-Aspartate Receptor-Independent Pathway Characterized by Mitochondrial Stress
Simon C. Baker et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment
Kathryn M. Schak et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A REVIEW OF KETAMINE ABUSE AND DIVERSION
Sean Sassano-Higgins et al.
DEPRESSION AND ANXIETY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Ketamine may be related to minor troponin elevations in children undergoing minor procedures in the ED
Mustafa Serinken et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2015)
Concomitant Benzodiazepine Use Attenuates Ketamine Response
Mark A. Frye et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Ketamine
Rachel Quibell et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)
Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia
Ke Xu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: Implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans
Ke Xu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring
Tianyun Zhao et al.
NEUROBIOLOGY OF DISEASE (2014)
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
James W. Murrough et al.
PSYCHOPHARMACOLOGY (2014)
Ketamine cystitis: practical considerations in management
Saumya Misra et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2014)
Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation
Celia J. A. Morgan et al.
FRONTIERS IN PSYCHIATRY (2014)
S-ketamine concentrations are greatly increased by grapefruit juice
Marko A. Peltoniemi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
St John's wort greatly decreases the plasma concentrations of oral S-ketamine
Marko A. Peltoniemi et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
Effect of Rifampicin on S-ketamine and S-norketamine Plasma Concentrations in Healthy Volunteers after Intravenous S-ketamine Administration
Ingeborg Noppers et al.
ANESTHESIOLOGY (2011)
Exposure to Oral S-ketamine Is Unaffected by Itraconazole but Greatly Increased by Ticlopidine
M. A. Peltoniemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
To use or not to use: an update on licit and illicit ketamine use
Jih-Heng Li et al.
SUBSTANCE ABUSE AND REHABILITATION (2011)
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
Celia J. A. Morgan et al.
ADDICTION (2010)
Infant With In Utero Ketamine Exposure: Quantitative Measurement of Residual Dosage in Hair
Pen-Hua Su et al.
PEDIATRICS AND NEONATOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
THE DESTRUCTION OF THE LOWER URINARY TRACT BY KETAMINE ABUSE: A NEW SYNDROME?
BJU INTERNATIONAL (2008)
Journey through the K-hole: Phenomenological aspects of ketamine use
L. Muetzelfeldt et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Attentional bias to incentive stimuli in frequent ketamine users
C. J. A. Morgan et al.
PSYCHOLOGICAL MEDICINE (2008)
A pediatric case of ketamine-associated cystitis (letter-to-the-editor re:: !Shahani R, !Streutker C, !Dickson B, et al:: Ketamine-associated ulcerative cystitis:: A new clinical entity.: Urology 69: 810-812, 2007)
Marie-Claude Gregoire et al.
UROLOGY (2008)
Ketamine-associated ulcerative cystitis: A new clinical entity
Rohan Shahani et al.
UROLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine
HS Cho et al.
PSYCHOPHARMACOLOGY (2005)
The rise of club drugs in a heroin society: The case of Hong Kong
KAJ Laidler
SUBSTANCE USE & MISUSE (2005)
Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug
CJA Morgan et al.
ADDICTION (2004)
Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
A Becker et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes
Y Hijazi et al.
DRUG METABOLISM AND DISPOSITION (2002)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
